Reuma Margalit Yehuda, Yana Davidov, Limor Selinger, Bella Ungar, Adi Lahat, Doron Yablecovitch, Sandra Neuman, Uri Kopylov, Shomron Ben Horin, Rami Eliakim, For the Israeli IBD Research Nucleus (IIRN)
{"title":"The Visibility and Performance of Small Bowel Video Capsule Endoscopy With and Without Pre-Procedural Purge Preparation in the Same Patients","authors":"Reuma Margalit Yehuda, Yana Davidov, Limor Selinger, Bella Ungar, Adi Lahat, Doron Yablecovitch, Sandra Neuman, Uri Kopylov, Shomron Ben Horin, Rami Eliakim, For the Israeli IBD Research Nucleus (IIRN)","doi":"10.1111/jgh.16954","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Small bowel (SB) video capsule endoscopy (VCE) is an established diagnostic tool for the investigation of SB pathologies. Despite clinical studies and a few meta-analyses, an area of continuing controversy is the role of pre-procedural bowel preparation.</p>\n </section>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>We compared the visibility and performance of VCE with and without purge preparation in the same patients.</p>\n </section>\n \n <section>\n \n <h3> Design</h3>\n \n <p>Post hoc analysis of randomized control trial.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This is a post hoc analysis of the prospective randomized CURE-CD Trial (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease trial). Established Crohn's disease (CD) patients in clinical remission were enrolled and classified into two groups according to relapse risk assessment. All patients are followed up in our clinic and undergo laboratory tests every 3 months and serial VCE studies every 6 months. The first VCE is done after bowel preparation with a clear liquid diet, PEG, and laxative, whereas the subsequent VCEs, when disease is confined to SB only, are done after a day on clear liquid diet. The VCE visibility is rated (1–4 points) by a blind observer, unaware to the preparation regimen.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Forty patients who underwent at least two VCEs, at baseline and after 6 months were included. Visibility scores were similar in these two time points (3.15 vs. 3.10, <i>p</i> = 0.8). Among the low-risk patients' group (<i>n</i> = 16) in whom the clinical parameters (CDAI, CRP, and fecal calprotectin) have not changed significantly during this period, Inflammatory scores assessed by the capsule Lewis score (LS) and PillCam-CD score (PCDS) were similar (median LS 225 vs. 225, <i>p</i> = 0.87, median PCDS 4 vs. 2, <i>p</i> = 0.37).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The visibility and performance of SB VCE for monitoring Crohn's disease is not significantly influenced by purge preparation.</p>\n \n <p><b>Trial Registration:</b> Clinicatrials.gov identifier: NCT03555058.</p>\n </section>\n </div>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":"40 6","pages":"1485-1491"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgh.16954","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jgh.16954","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Small bowel (SB) video capsule endoscopy (VCE) is an established diagnostic tool for the investigation of SB pathologies. Despite clinical studies and a few meta-analyses, an area of continuing controversy is the role of pre-procedural bowel preparation.
Objectives
We compared the visibility and performance of VCE with and without purge preparation in the same patients.
Design
Post hoc analysis of randomized control trial.
Methods
This is a post hoc analysis of the prospective randomized CURE-CD Trial (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease trial). Established Crohn's disease (CD) patients in clinical remission were enrolled and classified into two groups according to relapse risk assessment. All patients are followed up in our clinic and undergo laboratory tests every 3 months and serial VCE studies every 6 months. The first VCE is done after bowel preparation with a clear liquid diet, PEG, and laxative, whereas the subsequent VCEs, when disease is confined to SB only, are done after a day on clear liquid diet. The VCE visibility is rated (1–4 points) by a blind observer, unaware to the preparation regimen.
Results
Forty patients who underwent at least two VCEs, at baseline and after 6 months were included. Visibility scores were similar in these two time points (3.15 vs. 3.10, p = 0.8). Among the low-risk patients' group (n = 16) in whom the clinical parameters (CDAI, CRP, and fecal calprotectin) have not changed significantly during this period, Inflammatory scores assessed by the capsule Lewis score (LS) and PillCam-CD score (PCDS) were similar (median LS 225 vs. 225, p = 0.87, median PCDS 4 vs. 2, p = 0.37).
Conclusion
The visibility and performance of SB VCE for monitoring Crohn's disease is not significantly influenced by purge preparation.
期刊介绍:
Journal of Gastroenterology and Hepatology is produced 12 times per year and publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatology, gastroenterology and endoscopy. Papers cover the medical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas. All submitted papers are reviewed by at least two referees expert in the field of the submitted paper.